Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal-Bolus Therapy.

Diabetes Ther · 2019 · PMC6612353 · PMID 31168694

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

While the prevalence of diabetes in Japan has remained relatively stable over the past 20 years, except for an increasing trend in elderly age groups [ 2 ], it is expected to increase in Japan from 7.9% in 2010 to 9.8% by 2030 [ 7 ].

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.